Shree Ganesh Remedies Reports Declining Financial Metrics Amid Operational Challenges in June 2025
Shree Ganesh Remedies has reported its financial results for the quarter ending June 2025, revealing a decline in key metrics. Profit Before Tax is at Rs 3.94 crore, while Profit After Tax stands at Rs 3.45 crore. Net sales for the past six months total Rs 49.10 crore, indicating a contraction.
Shree Ganesh Remedies, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending June 2025. The results indicate a challenging period for the company, with notable shifts in its financial metrics.The Profit Before Tax less Other Income (PBT) for the quarter stands at Rs 3.94 crore, reflecting a significant decline compared to the previous year. Similarly, the Profit After Tax (PAT) has also shown a downward trend, recorded at Rs 3.45 crore. The net sales over the latest six months reached Rs 49.10 crore, which marks a contraction year-on-year.
Additionally, the operating profit has hit its lowest point in the last five quarters at Rs 7.30 crore, and the operating profit margin has decreased to 29.59%, indicating a decline in the company's operational efficiency. The Earnings per Share (EPS) has also reached a low of Rs 2.69, suggesting a reduction in profitability for shareholders.
In light of these developments, Shree Ganesh Remedies has experienced an adjustment in its evaluation, with its score reflecting these financial challenges.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
